U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Celebrity Inventors

Actor Zeppo Marx patented a "Cardiac Pulse Rate Monitor" in 1969.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: The Regents of the University of Colorado


Location: Denver, CO
No. of patents: 45

1    
NumberTitleIssue Date
8181544Liquid sample evaporator for vapor analysis
Preparation methods for introducing liquid samples to gas analysis instruments include 1) complete evaporation of a liquid sample in a sample chamber, and 2) allowing the sample vapor in the sample chamber to equilibrate for a predetermined time. An inert carrier ga...
05/22/2012
8170644Method for fast multi-slice mapping of myelin water fraction
Mapping of myelin water content in white matter may provide important information for early diagnosis of multiple sclerosis and the detection of white matter abnormality in other diseases. It is disclosed here that free induction decay (FID) of each voxel at multipl...
05/01/2012
8168415Axl fusion proteins as Axl tyrosine kinase inhibitors
Disclosed are novel inhibitors of the Axl receptor tyrosine kinase (RTK) and methods of using such inhibitors in a variety of therapeutic approaches in the areas of cancer therapy and anti-thrombosis (anti-clotting) therapy. ...
05/01/2012
8153136Yeast-based vaccines as immunotherapy
Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for treating and/or preventing cancer in an animal are described. Specifically...
04/10/2012
8137672Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
A synergistic adjuvant is provided comprising synergistically effective amounts of at least one type 1 interferon and at least one CD40 agonist, wherein these moieties may be in the same or separate compositions. In addition, fusion proteins and DNA conjugates which...
03/20/2012
8112594Efficient point-to-point enqueue and dequeue communications
Systems and methods for writing and/or reading data to a point-to-point shared memory communication mechanism are provided according to embodiments disclosed herein. According to one embodiment, a determination may be made whether a first memory location in the cach...
02/07/2012
8076304Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions
The present invention relates to compositions and methods for cancer therapeutics. In particular, the present invention provides compositions and methods for inhibiting cancer metastasis by inhibiting cyclin A1. ...
12/13/2011
8071645Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
Systems and methods for treating inflammatory and proliferative diseases, and wounds, using as a pharmacon a fatty acid metabolism inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, option...
12/06/2011
8007804Complement receptor 2 targeted complement modulators
Modulation of the complement system represents a therapeutic modality for numerous pathologic conditions associated with complement activation. In a strategy to prepare complement inhibitors that are targeted to sites of complement activation and disease, compositio...
08/30/2011
7956592Monitoring and control of power converters
A digital controller configured to inject a signal into a digital feedback path that facilitates regulation of a power converter and measure the corresponding phase, gain, or frequency. The digital controller may also include an adaptive tuning controller for adjust...
06/07/2011
7943680Stress relaxation in crosslinked polymers
The invention provides methods for inducing reversible chain cleavage of polymer chains in a crosslinked polymeric material. Reversible cleavage of the polymer backbone is capable of relieving stress in the polymeric material as the bonds reform in a less stressed s...
05/17/2011
7931824Surfactants and polymerizable surfactants based on room-temperature ionic liquids that form lyotropic liquid crystal phases with water and room-temperature ionic liquids
A modular surfactant architecture based on room temperature ionic liquids (RTILs) has been developed that affords non-polymerizable and polymerizable amphiphiles that form lamellar (L), hexagonal (H) or bicontinuous cubic (Q) LLC phases when mixed with water or RTIL...
04/26/2011
7915285Method for treating drug and behavioral addictions
The present invention is directed to the use of ibudilast for treating addictions, including drug and behavioral addictions. In particular, ibudilast is used to diminish the dopamine-mediated reward associated with addictions and to treat withdrawal syndromes after ...
03/29/2011
7914714Methods and apparatus using electrostatic atomization to form liquid vesicles
The methods of the invention employ electrostatic atomization to form a compound droplet of at least two miscible fluids. The compound droplet comprises a core of a first fluid and a layer of a second fluid completely surrounding the core. The first fluid contains t...
03/29/2011
7902803Digital current mode controller
A digital current-mode controller for a DC-DC converter is disclosed. The controller comprises a digital current reference; and a current loop compensator adapted to receive a digital current error signal derived from a digital current sample sensed from the DC-DC c...
03/08/2011
7846688Broad host range vectors for shotgun and expression library cloning in Gram negative bacteria
The present invention concerns methods and compositions for the construction of a series of stable vectors for genomic library construction useful in Gram negative species. In certain embodiments, the vectors contain the pBBR1 replicon, capable of to stable replicat...
12/07/2010
7858349Anti-cancer compounds
The invention provides bradykinin antagonists and pharmaceutically acceptable salts thereof having anti-cancer activity. These anti-cancer compounds are particularly useful for inhibiting the growth of lung and prostate cancers. ...
12/28/2010
7850970Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
A novel method of treating and preventing bacterial diseases is provided. In particular, the present invention relates to compositions and methods for inhibition of Gram negative, Gram positive and acid fast bacilli in general and tuberculosis (TB), mycobacterium...
12/14/2010
7842485Enhanced alcohol tolerant microorganism and methods of use thereof
Embodiments of the present invention provide methods and compositions for microorganisms having increased alcohol tolerance. In certain embodiments, methods for using such microorganisms, and methods for identifying gene or genetic regions responsible for increased ...
11/30/2010
7838571Photopolymers and use in dental restorative materials
Photopolymerizable polymer composites based on dimethacrylate systems have been increasingly utilized as dental restorative materials. One of the biggest drawbacks of current dental resin systems is the volume shrinkage and shrinkage induced stresses that arise duri...
11/23/2010
7828875Membranes for highly selective separations
The present invention provides modified molecular sieve membranes with improved CO2/CH4 separation selectivity and methods for making such membranes. The molecular sieve membranes are modified by adsorption of a modifying agent, such as ammonia...
11/09/2010
7807781Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections
A novel method of treating and preventing viral infection is provided. In particular a method of blocking viral infection facilitated by a serine proteolytic (SP) activity is disclosed, which consists of administering to a subject suffering or about to suffer from v...
10/05/2010
7764023Capacitive coupling to aid ignition in discharge lamps
A method and apparatus for aiding ignition in a discharge lamp is provided. In one embodiment, a method comprises: applying a voltage across a pair of electrodes of a discharge lamp and capacitively coupling the discharge lamp. The capacitive coupling of the dischar...
07/27/2010
7763259Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
This invention provides compositions including a chimera of papillomavirus capsid polypeptide L2 and polypeptide including an immunotherapeutic epitope, and GST fusions thereof. The present invention also provides complexes comprising chimeras of papillomavirus L2 p...
07/27/2010
7760342Multidimensional spectrometer
A multidimensional spectrometer for the infrared, visible, and ultraviolet regions of the electromagnetic spectrum, and a method for making multidimensional spectroscopic measurements in the infrared, visible, and ultraviolet regions of the electromagnetic spectrum....
07/20/2010
7749490Mutant IL-10
IL-10 sequence variants are disclosed that retain the therapeutically desirable anti-inflammatory properties of wild-type IL-10 but do not retain the hemoatopoeitic cell regulatory and cell proliferative activities. The mutant IL-10 polypeptides of the invention are...
07/06/2010
7732750Wavefront coding interference contrast imaging systems
An interference contrast imaging system images phase objects. The system includes an illumination source, illumination optics, polarizing optics for splitting the illumination into orthogonal polarizations and for recombining the polarizations, objective optics that...
06/08/2010
7705970Method and system for optical imaging and ranging
The distance of objects to an optical system is estimated. An optical mask such as a diffractive optical element, continuous phase mask, hologram, amplitude mask, or combination thereof is placed within the optics in front of a sensor array such as a CCD, CID or COM...
04/27/2010
7660698Phytometric intelligence sensors
Methods and apparatus for determining when plants require watering, and methods of attending to the watering of plants including signaling the grower that the plants are in need of hydration are provided. The novel methods include real-time measurement of plant meta...
02/09/2010
7612733Transition region for use with an antenna-integrated electron tunneling device and method
An electron tunneling device includes a first non-insulating strip and a second non-insulating strip spaced apart from one another such that first and second end portions, respectively, of the first and second non-insulating strips cooperate to form an antenna havin...
11/03/2009
7608611Hsp90 inhibitors, methods of making and uses therefor
The invention provides purified 18,21-didehydro-18,21-dideoxo-18,21-dihydroxy-geldanamycin derivatives, pharmaceutically acceptable salts thereof and prodrugs thereof that are potent Hsp90 binding agents that are useful for the treatment and/or the amelioration of s...
10/27/2009
7595060Yeast-antigen compositions methods of making the same
Disclosed is a vaccine that includes a dendritic cell loaded with a yeast vehicle and antigen. Also disclosed are methods of making the vaccine and using the vaccine to elicit cellular and humoral immune responses in a mammal. Additionally, a method to elicit an imm...
09/29/2009
7572908Cleavable linkers for polynucleotides
In various embodiments of the invention, novel compositions having a polynucleotide bound to a substrate via a cleavable linker are provided, and methods of cleaving a polynucleotide from a substrate are provided. ...
08/11/2009
7572907Methods and compounds for polynucleotide synthesis
Methods of forming polynucleotides are disclosed. ...
08/11/2009
7510710Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
Systems and methods for treating inflammatory and proliferative diseases, and wounds, using as a pharmacon a UCP and/or Fas antibody or other inhibitor, or combination thereof, and a therapeutically acceptable amount of a fatty acid metabolism inhibitor and/or a the...
03/31/2009
7485307Human cystathionine β-synthase variants and methods of production thereof
Human cystathionine β-synthase variants are disclosed, as well as a method to produce recombinant human cystathionine β-synthase and variants thereof. More particularly, the role of both the N-terminal and C-terminal regions of human CBS has been studied, and a va...
02/03/2009
7470431Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
The present invention related to methods for treating neurological-urological conditions associated with prostate cancer or methods of treatment of prostate cancer, which is accomplished by administration of botulinum toxin to the patient. ...
12/30/2008
7455845Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
The present invention related to methods for treating neurological-urological conditions, including urinary retention. This is accomplished by administration of a botulinum toxin into the lower urinary tract of a patient with urinary retention, including the bladder...
11/25/2008
7449192Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
The present invention related to methods for treating neurological-urological conditions, including neurogenic bladder dysfunction. This is accomplished by administration of a botulinum toxin into the lower urinary tract of a patient with a neurogenic bladder dysfun...
11/11/2008
7445794Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors
The present invention generally relates to systems and methods for treating inflammatory and proliferative diseases, and wounds, using a combination of (1) fatty acid metabolism inhibitors and (2) glycolytic inhibitors and/or UCP and/or Fas inhibitors or antibodies....
11/04/2008
1    
 
Sign InRegister
Username  
Password   
forgot password?